189 related articles for article (PubMed ID: 38622813)
1. Copper: From enigma to therapeutic target for neurological disorder.
Patwa J; Flora SJS
Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):778-791. PubMed ID: 38622813
[TBL] [Abstract][Full Text] [Related]
2. Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.
Ejaz HW; Wang W; Lang M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081348
[TBL] [Abstract][Full Text] [Related]
3. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
4. Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
Squitti R; Faller P; Hureau C; Granzotto A; White AR; Kepp KP
J Alzheimers Dis; 2021; 83(1):23-41. PubMed ID: 34219710
[TBL] [Abstract][Full Text] [Related]
5. Dynamic nanoassemblies for imaging and therapy of neurological disorders.
Zhang L; Sun H; Zhao J; Lee J; Ee Low L; Gong L; Chen Y; Wang N; Zhu C; Lin P; Liang Z; Wei M; Ling D; Li F
Adv Drug Deliv Rev; 2021 Aug; 175():113832. PubMed ID: 34146626
[TBL] [Abstract][Full Text] [Related]
6. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
7. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
[TBL] [Abstract][Full Text] [Related]
8. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.
Mishra A; Bandopadhyay R; Singh PK; Mishra PS; Sharma N; Khurana N
Metab Brain Dis; 2021 Oct; 36(7):1591-1626. PubMed ID: 34387831
[TBL] [Abstract][Full Text] [Related]
10. Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.
Esmieu C; Guettas D; Conte-Daban A; Sabater L; Faller P; Hureau C
Inorg Chem; 2019 Oct; 58(20):13509-13527. PubMed ID: 31247877
[TBL] [Abstract][Full Text] [Related]
11. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
[TBL] [Abstract][Full Text] [Related]
12. Copper and Alzheimer's Disease.
Mathys ZK; White AR
Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications.
Giri PM; Banerjee A; Ghosal A; Layek B
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612804
[TBL] [Abstract][Full Text] [Related]
14. Effects of Naodesheng tablets on amyloid beta-induced dysfunction: A traditional Chinese herbal formula with novel therapeutic potential in Alzheimer's disease revealed by systems pharmacology.
Zhang B; Zhao J; Guo P; Wang Z; Xu L; Liu A; Du G
Biomed Pharmacother; 2021 Sep; 141():111916. PubMed ID: 34328103
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
Cooper GJ
Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
[TBL] [Abstract][Full Text] [Related]
16. Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone-Pyridylhydrazone Copper(II) Complex.
Choo XY; McInnes LE; Grubman A; Wasielewska JM; Belaya I; Burrows E; Quek H; Martín JC; Loppi S; Sorvari A; Rait D; Powell A; Duncan C; Liddell JR; Tanila H; Polo JM; Malm T; Kanninen KM; Donnelly PS; White AR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142627
[TBL] [Abstract][Full Text] [Related]
17. Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases.
Singh K; Sethi P; Datta S; Chaudhary JS; Kumar S; Jain D; Gupta JK; Kumar S; Guru A; Panda SP
Ageing Res Rev; 2024 Jul; 98():102321. PubMed ID: 38723752
[TBL] [Abstract][Full Text] [Related]
18. The role of aluminum and copper on neuroinflammation and Alzheimer's disease.
Campbell A
J Alzheimers Dis; 2006 Nov; 10(2-3):165-72. PubMed ID: 17119285
[TBL] [Abstract][Full Text] [Related]
19. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
20. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
